21 May 2013
Keywords: Bayer, Pharma growth targets, Pipeline, Investor conference
Article | 15 March 2012
German drugs and crop sciences major Bayer (BAY: DE) sees good perspectives for its businesses in the medium term. Speaking ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
15 March 2012
14 March 2012
20 May 2013
© 2013 thepharmaletter.com